Ironsides Asset Advisors, LLC Orchard Therapeutics PLC Transaction History

Ironsides Asset Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$0.36 - $0.49 $25 - $34	-70 Reduced 0.66%	10,581 $4,000
Q2 2022 Aug 09, 2022	SELL	$0.42 - $0.78 $29 - $54	-70 Reduced 0.65%	10,651 $6,000
Q4 2021 Feb 04, 2022	SELL	$1.16 - $2.23 $319 - $613	-275 Reduced 2.5%	10,721 $14,000
Q3 2021 Nov 16, 2021	SELL	$2.24 - $4.29 $1,478 - $2,831	-660 Reduced 5.66%	10,996 $25,000
Q2 2021 Aug 06, 2021	SELL	$4.39 - $7.23 $10,667 - $17,568	-2,430 Reduced 17.25%	11,656 $51,000
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $5,790 - $7,605	1,500 Added 11.92%	14,086 $61,000
Q3 2020 Nov 10, 2020	BUY	$4.11 - $6.45 $3,456 - $5,424	841 Added 7.16%	12,586 $52,000
Q1 2020 May 11, 2020	BUY	$5.65 - $15.71 $66,359 - $184,513	11,745 New	11,745 $88,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Ironsides Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ironsides Asset Advisors, LLC with notifications on news.